Metactive Medical, Inc. (“Metactive”) announced that it was awarded top prize in a business plan competition hosted by the
Medical Device Entrepreneur’s Forum, a special session held on June 20, 2014 at the ASAIO 60th Annual Conference in Washington, DC. F. Nicholas Franano, MD, President and Chief Executive Officer of Metactive, presented to a group of experts in medical device development and commercialization, venture capital, reimbursement, and regulatory affairs. Metactive placed first among a selected group of companies with innovative medical devices used for the treatment or diagnosis of disease.
“The role that ASAIO has played in bringing together a diverse group of creative and entrepreneurial scientists, engineers, clinicians, and industry representatives has been a critical factor in the development of a wide range of life saving technologies that we rely on today, including hemodialysis machines, ventricular assist devices, and extracorporeal membrane oxygenators, among many others,” said Dr. Franano. “I know of no better place where medical device inventors and innovators can find fellow travelers, collaborators and friends. I’m honored that Metactive was recognized by this group.”
ASAIO (formerly known as the American Society for Artificial Internal Organs) is a premier society founded in 1955 for physicians, scientists, engineers, and entrepreneurs dedicated to the continually evolving fields of artificial organs, medical devices, and tissue engineering. For more information visit www.asaio.com.
About Metactive Medical
Metactive is developing novel endovascular medical devices for the treatment of neurovascular and peripheral vascular diseases. Metactive's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. For more information, please visit www.metactivemedical.com.